Episodes: 25
Frequency: Monthly
Rating: 4.8/5.0
Estimated listeners: < 100
Gender skew: Neutral
Listener location: USA
Page updated: Nov 11, 2026 · How we check this data
Publicly listed emails
ajmachado@me.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Michael Hostetler - Co-host covering life sciences venture capital, biotech investing, and healthcare company building.
Jen Fang - Co-host covering life sciences venture capital, biotech investing, and healthcare company building.
Jason Pitts - Biotech Investing, Neuroscience, Clinical Rigor, Career Development, And Evaluating Early-stage Healthcare Companies.
Suman Rao - Healthcare Venture Capital, Mission-driven Investing, Sidecar Funds, Investing Beyond Traditional Biotech Hubs, And The Histosonics Exit.
Aimee Raleigh - Building Biotech Companies From Inception, Evaluating Early Science, Forming Investment Conviction, And Early-stage Venture Decisions.
The Scientist Who Said Yes to Everything — and Ended Up in VC
October 30, 2026
Nandita Shangari didn’t plan to end up in venture capital. She was a toxicologist at Novartis, and said yes to one unplanned opportunity after another, until she’d worked on Kymriah (the first FDA-approved CAR T therapy), ran the Novartis Venture Fund, and ultimately landed at RA Capital Management, where she’s now Managing Director.In this episode, Jen and Mike trace that path with her and get into what she’s learned along the way about the “performance equity” that opens doors, how RA’s inc...
Why the Future of Biotech Starts With the Brain
July 07, 2026
What does neuroscience have to do with venture capital? Quite a bit, according to Jason Pitts.In this episode of the NextGen VC podcast, Mike Hostetler and Jen Fang sit down with Jason, Principal at General Atlantic, to talk about the winding path that took him from studying the brain at Cornell to evaluating some of the most promising companies in biotech.Jason shares how a series of unexpected opportunities led him from the lab at Regeneron to McKinsey and ultimately into venture investing....
The $2.25B Exit That Changed Lumira's Investment Strategy
June 08, 2026
Jen and Mike sit down with Dr. Suman Rao, Principal at Lumira Ventures, to discuss her path from academic science to healthcare venture capital and why she believes the best investors lead with mission before money.Rao shares Lumira’s approach to investing beyond traditional biotech hubs, the firm’s sidecar fund model with partners like Merck and the Terry Fox Foundation, and the story behind Histosonics, a Midwest medtech company that grew into a $2.25B exit and helped shape Lumira’s next in...
First in Human · Medium booking difficulty · 100 - 1,000 listeners
IDEA Collider: Innovation & Asymmetric Learning in Pharma · Medium booking difficulty · 100 - 1,000 listeners
The AUScelerate Podcast · Low booking difficulty · 100 - 1,000 listeners
The NextGen VC Podcast is hosted by Michael Hostetler and Jen Fang. Its publicly listed email is ajmachado@me.com. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed email for The NextGen VC Podcast: ajmachado@me.com.
Podseeker estimates The NextGen VC Podcast reaches fewer than 100 listeners per episode. Only the publisher has exact numbers.
The NextGen VC Podcast typically books rising experts. Typical guest background: Principals and experienced investors at life sciences venture firms, biotech or medtech founders, academic scientists with company-building or investment experience, and healthcare innovation professionals. Common among recent guests: Leading or evaluating early-stage biotech and healthcare investments; Building biotech companies from inception; Advanced scientific or academic training. Recent guests include Jason Pitts, Suman Rao, and Aimee Raleigh.
Medium. Guests usually need solid credentials in the topic and an idea that fits the show.
Recent episodes cover Venture Capital, Life Sciences, Biotechnology, Medtech, and Healthcare. Pitch an idea tied to one of these topics and mention a recent episode.
From public sources and our own research: podcast websites, social profiles, podcast feeds, and our data team. Podcast feeds and episodes are checked daily, and details like contacts, recent guests, and booking difficulty are refreshed regularly.
If something here is out of date, ask us to correct it through Podseeker's contact form at podseeker.co/contact. Our research team reviews every request and updates the listing.
Publicly listed emails
ajmachado@me.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings